P. Romero

Discipline

History, Philosophy and Sociology of Sciences (11) Economies and finances (3) Psychology (2) Communication sciences (2) Sociology (1) Linguistics (1)

Type

Articles (115) Reviews (11) Others (1)

Co-author

Date

Source

Keyword

T cells (70) Cells (69) Human beings (61) Cancer (55) cancer (50) Cancer (50) Immunotherapy (46) Immunotherapy (46) Patients (44) Patients (44) Melanoma (42) Expression (34) Mice (32) Antigens (32) Tumors (27) Receptors (26) Treatment (25) show (24) Tumors (24) Vaccination (21) Vaccination (21) Animals (20) protein (19) novel (19) analysis (18) Development (18) Example (18) Analysis (18) well (17) immunity (17)

Documents written by P. Romero (116) | is about P. Romero (0)

Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.
A. Almeida et al. (Mar 15, 2024)
Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer.
E. Desponds et al. (Jan 19, 2024)
Methionine oxidation selectively enhances T cell reactivity against a melanoma antigen.
G.N. Chiriţoiu et al. (Jul 21, 2023)
Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer.
R. Ahmed et al. (Jun 8, 2023)
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells.
S.J. Carmona et al.
Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models.
A. Boulay et al. (Mar 1, 2023)
Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy.
A. Sarivalasis et al. (2023)
The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function.
M. Wenes et al. (May 3, 2022)
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.
P. Muñoz et al. (2022)
Therapeutic cancer vaccines revamping: technology advancements and pitfalls.
G. Antonarelli et al.
Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity.
N. Dumauthioz et al.
CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas.
J.V. Santos et al.
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity.
Y. Guo et al.
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.
G. Ercolano et al. (May 5, 2021)
Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer.
M. Saillard et al. (May 4, 2021)
Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression.
E. Lanitis et al. (Feb 1, 2021)
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer.
A. Cachot et al.
Cholinergic Signaling Attenuates Pro-Inflammatory Interleukin-8 Response in Colonic Epithelial Cells.
I. Müller et al. (2021)
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus.
R. Lande et al. (Apr 3, 2020)
miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen.
G.C. Monnot et al. (Mar 27, 2020)
An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma.
P. Lasso et al. (2020)
Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells.
S.J. Carmona et al. (2020)
Moving cancer immunotherapy forward through the Journal for ImmunoTherapy of Cancer (JITC).
P. Romero
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
B. Salomé et al. (Nov 26, 2019)
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells.
B. Navarro Rodrigo et al. (Oct 10, 2019)

next